Integrated genomics of chemotherapy resistant ovarian cancer: A role for extracellular matrix, TGFbeta and regulating microRNAs

被引：46

作者：

Helleman, Jozien ^{[1
]}

Jansen, Maurice P. H. M. ^{[1
]}

Burger, Curt ^{[2
]}

van der Burg, Maria E. L. ^{[1
]}

Berns, Els M. J. J. ^{[1
]}

机构：

[1] Erasmus MC, Dept Med Oncol, Josephine Nefkens Inst, NL-3000 CA Rotterdam, Netherlands

[2] Erasmus MC, Dept Gynaecol, NL-3000 CA Rotterdam, Netherlands

来源：

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY | 2010年 / 42卷 / 01期

关键词：

Ovarian cancer; Chemotherapy resistance; Extracellular matrix; TGFbeta; Epithelial to mesenchymal transition; miRNAs; BREAST-CANCER; MESENCHYMAL TRANSITION; ANTICANCER DRUGS; EXPRESSION; CELLS; CHEMORESISTANT; STABILIZATION; METASTASIS; CARCINOMAS; MECHANISMS;

D O I：

10.1016/j.biocel.2009.10.016

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

070307 [化学生物学]; 071010 [生物化学与分子生物学];

摘要：

Epithelial ovarian cancer is the sixth most common cancer in women worldwide and the most important cause of death from gynaecological cancers in the Western world. Our explorative pathway analysis on seven published gene-sets associated with platinum resistance in ovarian cancer reveals TP53 and transforming growth factor beta as key genes. Furthermore, the extracellular matrix was associated with chemotherapy resistance in ovarian cancer as well as endocrine resistance in breast cancer. Pathway analysis again revealed transforming growth factor beta as a key gene regulating extracellular matrix gene expression. A model is presented based on literature linking transforming growth factor beta, extracellular matrix, integrin signalling, epithelial to mesenchymal transition and regulating microRNAs; with a (bivalent) role in chemotherapy response. (C) 2009 Elsevier Ltd. All rights reserved.

引用

页码：25 / 30

页数：6

共 45 条

[1]

The extracellular matrix protein TGFBI induces microtubule stabilization and sensitizes ovarian cancers to paclitaxel [J].

Ahmed, Ahmed Ashour ;

Mills, Anthony D. ;

Ibrahim, Ashraf E. K. ;

Temple, Jillian ;

Blenkiron, Cherie ;

Vias, Maria ;

Massie, Charlie E. ;

Iyer, N. Gopalakrishna ;

McGeoch, Adam ;

Crawford, Robin ;

Nicke, Barbara ;

Downward, Julian ;

Swanton, Charles ;

Bell, Stephen D. ;

Earl, Helena M. ;

Laskey, Ronald A. ;

Caldas, Carlos ;

Brenton, James D. .

CANCER CELL, 2007, 12 (06) :514-527

[2]

Bachvarov D, 2006, INT J ONCOL, V29, P919

[3]

The biology of ovarian cancer: new opportunities for translation [J].

Bast, Robert C., Jr. ;

Hennessy, Bryan ;

Mills, Gordon B. .

NATURE REVIEWS CANCER, 2009, 9 (06) :415-428

[4]

Tumor necrosis factor-α stimulates the epithelial-to-mesenchymal transition of human colonic organoids [J].

Bates, RC ;

Mercurio, AM .

MOLECULAR BIOLOGY OF THE CELL, 2003, 14 (05) :1790-1800

[5]

High-resolution mapping of genomic imbalance and identification of gene expression profiles associated with differential chemotherapy response in serous epithelial ovarian cancer [J].

Bernardini, M ;

Lee, CH ;

Beheshti, B ;

Prasad, M ;

Albert, M ;

Marrano, P ;

Begley, H ;

Shaw, P ;

Covens, A ;

Murphy, J ;

Rosen, B ;

Minkin, S ;

Squire, JA ;

Macgregor, PF .

NEOPLASIA, 2005, 7 (06) :603-613

[6]

A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells [J].

Burk, Ulrike ;

Schubert, Joerg ;

Wellner, Ulrich ;

Schmalhofer, Otto ;

Vincan, Elizabeth ;

Spaderna, Simone ;

Brabletz, Thomas .

EMBO REPORTS, 2008, 9 (06) :582-589

[7]

Cancer of the ovary [J].

Cannistra, SA .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (24) :2519-2529

[8]

COCHRANE DR, 2009, MOL CANC THER MAY

[9]

Review - Proteases, extracellular matrix, and cancer - A workshop of the path B study section [J].

DeClerck, YA ;

Mercurio, AM ;

Stack, MS ;

Chapman, HA ;

Zutter, MM ;

Muschel, RJ ;

Raz, A ;

Matrisian, LM ;

Sloane, BF ;

Noel, A ;

Hendrix, MJ ;

Coussens, L ;

Padarathsingh, M .

AMERICAN JOURNAL OF PATHOLOGY, 2004, 164 (04) :1131-1139

[10]

RETRACTED: An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer (Retracted article. See vol. 30, pg. 678, 2012) [J].

Dressman, Holly K. ;

Berchuck, Andrew ;

Chan, Gina ;

Zhai, Jun ;

Bild, Andrea ;

Sayer, Robyn ;

Cragun, Janiel ;

Clarke, Jennifer ;

Whitaker, Regina S. ;

Li, LiHua ;

Gray, Jonathan ;

Marks, Jeffrey ;

Ginsburg, Geoffrey S. ;

Potti, Anil ;

West, Mike ;

Nevins, Joseph R. ;

Lancaster, Johnathan M. .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (05) :517-525

← 1 2 3 4 5 →